NCT01387074 - Observational Study of Botox® Treatment for Patients With Upper Limb Adult Spasticity | Biotech Hunter

Enrollment

108

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions

Muscle Spasticity

Interventions

BIOLOGICAL

botulinum toxin Type A

Botulinum toxin Type A treatment at a dose determined by the physician at Baseline followed by a second botulinum toxin Type A treatment approximately 12 weeks later if applicable.

Trial Locations (1)

Unknown

Itzehoe